RubrYc Therapeutics

About:

RubrYc Therapeutics is a biotechnology company.

Top Investors: iBio, Paladin Capital Group, Third Point Ventures, Vital Venture Capital, Hayan Health Networks

Description:

RubrYc Therapeutics is a biotechnology company that integrates chemistry and computation to decode therapeutically significant protein interfaces, revolutionizing the discovery of antibody-based drugs. RubrYc Therapeutics using disruptive innovation to deliver fresh insights into the design and development of therapeutic antibodies. Inspired by recent advancements in molecular library synthesis, massively parallel screening and computing, they are forging a new path for information-driven discovery of therapeutic antibodies.

Total Funding Amount:

$17.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Ramon, California, United States

Founded Date:

2017-01-01

Founders:

Isaac Bright, Matthew Greving, Mohan Srinivasan

Number of Employees:

11-50

Last Funding Date:

2021-08-25

IPO Status:

Private

Industries: